Bill Snyder

Vanderbilt University cancer researcher Ann Richmond, Ph.D., has won the 2016 William S. Middleton Award, the highest honor for scientific achievement bestowed by the Biomedical Laboratory Research and Development Service of the U.S. Department of Veterans Affairs (VA). Read More

On Tuesday, Oct. 4, the Cell Imaging Shared Resource (CISR) at Vanderbilt University Medical Center (VUMC) will officially unveil its new Nikon Center of Excellence, which will feature state-of-the-art microscopy for live cell imaging. Read More

Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017. Read More

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea. Read More

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide. Read More

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read More

William G. Kaelin, Jr., M.D., professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of the Vanderbilt University Medical Center (VUMC) Biomedical Science Advisory Board, has been named a winner… Read More

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice. Read More

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” Read More

Diversity. Inclusion. Excellence. Innovation. You can’t have one without the others. Read More

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read More

A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. Read More

Vanderbilt University welcomed 92 new doctoral students Sept. 2 during the seventh annual Simple Beginnings ceremony in a Light Hall lecture room packed with family members and other well wishers. Read More

The importance of diversity and inclusion to medical and graduate education and research will be discussed on Sept. 8 during the first Flexner Discovery Lecture of the 2016-2017 academic year. Read More

A protein that plays a powerful role in learning and memory may be a key to improving treatment of a rare autism spectrum disorder called Pitt-Hopkins syndrome (PTHS), a new study suggests. Read More

A broad and diverse group of 150 Medical Center and University leaders, students, and community stakeholders met Monday afternoon at the Vanderbilt Student Life Center to advance Vanderbilt University Medical Center’s Strategy Framework process. Read More

Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation. Read More

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine. Read More

Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently. Read More

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read More